Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

25,120 signal articles · 224 in last 24h · 119,779 total before filter · latest 47m ago
224last 24h
1425last 7d
239● bullish (7d)
157● bearish (7d)
205publishers
AllMacro256Earnings543M&A102Regulatory19Product10Analyst23
✕ clear all filtersticker: AXPSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
American Express (AXP) Preferred Offering Puts Its Undervalued Narrative Back In Focus
Simply Wall St.11d agoneutral
American Express (AXP) Preferred Offering Puts Its Undervalued Narrative Back In Focus

American Express (AXP) has drawn fresh attention after completing a US$1.6b fixed income offering of preferred depository shares, giving investors another lens on the company alongside its common stock performance and recent earnings commentary. See our latest analysis for American Express. Against this backdrop, American Express shares trade at US$340.91, with a 90 day share price return of 7.87% even as the year to date share price return is down 8.54%. The 5 year total shareholder return...

TripAdvisor Q2 Earnings Call Highlights
MarketBeat12d agoneutral
TripAdvisor Q2 Earnings Call Highlights

TripAdvisor (NASDAQ:TRIP) reported second-quarter results in line with its expectations as growth in its experiences business was offset by persistent search-related pressure in legacy offerings and uneven travel demand. The company also said it expects to complete the sale of restaurant reservation

SRX Global Acquires Stake in Vistagen Therapeutics
InvestorsHub15d agoneutral
SRX Global Acquires Stake in Vistagen Therapeutics

SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).

3 Reasons Investors Watch American Express (AXP)
StockStory16d agoneutral
3 Reasons Investors Watch American Express (AXP)

Since February 2026, American Express has been in a holding pattern, posting a small loss of 3.2% while floating around $338.50. The stock also fell short of the S&P 500’s 8.3% gain during that period.

How Investors Are Reacting To American Express (AXP) Raising 2026 Revenue Outlook While Keeping EPS Steady
Simply Wall St.16d agoneutral
How Investors Are Reacting To American Express (AXP) Raising 2026 Revenue Outlook While Keeping EPS Steady

In July 2026, American Express reported higher second-quarter net income of US$3,110 million and raised its full-year 2026 revenue growth guidance to 10%, while maintaining earnings-per-share guidance at US$17.30 to US$17.90 and completing a share buyback of 74,093,544 shares for US$18.32 billion under its 2023 program. The company’s decision to upgrade revenue expectations while holding EPS guidance steady highlights its choice to reinvest in customer acquisition, technology, and lifestyle...